Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers November 22, 2017
Pharmacy Choice - Pharmaceutical News - Biosimilars Market Is Expected to Reach USD 58.40 Billion by 2022 - November 22, 2017

Pharmacy News Article

 2/16/17 - Biosimilars Market Is Expected to Reach USD 58.40 Billion by 2022

The biosimilars market offers many growth opportunities and driving factors as compared to the restraining factors. It is stated by various research scientists that development of biosimilars will drastically reduce the price of the pharmaceutical drugs.Chicago, IL (SBWIRE) 02/16/2017 The global biosimilars market report offers in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key players, premium trends and forecast to 2022. It also focuses on the key drivers and opportunities in this market.

Browse Report & Table of Content: https://www.scalarmarketresearch.com/market-reports/biosimilars-market

Early buyers can expect to receive 10% customization on this report.

Key findings of the report:
The rising demand and awareness towards the applications of biosimilars are considered as one of the major driving factors for the biosimilars market, during the forecast period.
The majority of the top market players are investing in the biosimilars market, creating strong growth opportunities for the market in the near future.

The biosimilars are considered as one of the most promising options for the treatment of various chronic diseases. The rising instances of various diseases such as cancer and cardiovascular diseases are also expected to drive the demand in the biosimilars market.

Oncology is the fastest growing market in the application segment
Oncology was the largest application segment of the biosimilars market in 2015. According to the report, oncology is expected to remain the fastest growing application segment, due to the rise in the aging population, the increased prevalence of cancer, and the rising number of patients with the hospital-acquired diseases.

Request Sample: https://www.scalarmarketresearch.com/request-sample.php?id=9

North America: Anticipated to dominate the biosimilars market
The North America region is expected to dominate the global biosimilars market based on the total market share, due to the rising demand for the biosimilars products. The Europe region is also considered to be the potential market for biosimilars, due to the impressive growth in the research and development activities in the region.

Make an Enquiry: https://www.scalarmarketresearch.com/enquire-before-buy.php?id=9

The key players highlighted in the biosimilars market report include:
Actavis
Amgen
Biocon Ltd.
Cipla Ltd.
Hospira, Inc.
Sandoz Pharma
Stada Arzneimittel AG
Wockhardt Ltd.
Others

Browse Related Reports:
Prescription Pharmaceuticals Market, by Therapeutic Segments (Cardiovascular Disorders, Inflammatory Conditions, Metabolic Disorders, Oncology, Respiratory Disorders, Others), Formulations (Capsules, Inhalants, Parenterals, Tablets, Topicals) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2020
https://www.scalarmarketresearch.com/market-reports/prescription-pharmaceuticals-market

Stem Cell Therapy Market, by Treatments (Allogeneic Stem Cell Therapy and Autologous Stem Cell Therapy), Applications (Central Nervous System Diseases, Eye Diseases, Musculoskeletal Diseases, Wound & Injuries, Metabolic Disorders, Cardiovascular Disorders, Gastrointestinal Disorders and Immune System Disorders), End-users (Hospitals and Ambulatory Surgical Centers) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022
https://www.scalarmarketresearch.com/market-reports/stem-cell-therapy-market

About Scalar Market Research
Scalar Market Research, Inc., a U.S.-based market research and consulting firm, assists organizations from around the world to achieve their business goal with premium market research reports and consulting services. Our real-time industry tracking with the help of advanced analytics offers a crystal clear view of all the activities in niche markets. Our team, with thorough global understanding, works relentlessly to gather the necessary market insights, including customer analysis, competitions and global forecast.
Find out more about our services at: http://www.scalarmarketresearch.com
Contact:
Mr. Moses Nakka
8770 W Bryn Mawr Ave.,
Suite 1300
Chicago, IL 60631
Tel.: +1-800-213-5170 (U.S./Canada Toll-free)
Email: sales@scalarmarketresearch.com
Follow us on LinkedIn: https://www.linkedin.com/company/scalar-market-researchFor more information on this press release visit: http://www.sbwire.com/press-releases/biosimilars-market-is-expected-to-reach-usd-5840-billion-by-2022-771741.htm

Media Relations Contact

Moses Nakka
Vice President Marketing
Scalar Market Research
Telephone: 1-800-213-5170
Email: Click to Email Moses Nakka
Web: https://www.scalarmarketresearch.com/market-reports/biosimilars-market




Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Nov 27: Drug Diversion and the Law: Updates and Considerations
Nov 28: An Integrative Approach to Managing Arthritis
Nov 29: Influenza 2017-2018: An Update on Prevention and Treatment
Nov 30: School is Out! Life is in Session: The Importance of Professional Development in Pharmacy
Dec 01: Anticoagulants: The Rapidly Changing Landscape
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415